A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection

Chang K.-C.Tseng P.-L.Wu Y.-Y.Hung H.-C.Huang C.-M.Lu S.-N.Wang J.-H.Lee C.-M.Chen C.-H.Tsai M.-C.Yen Y.-H.Lin M.-T.Wu C.-K.Huang C.-C.Chen, Tony Hsiu HsiTony Hsiu HsiChenHu T.-H.2022-04-212022-04-2120151542-3565https://www.scopus.com/inward/record.uri?eid=2-s2.0-84927912814&doi=10.1016%2fj.cgh.2014.10.035&partnerID=40&md5=507648615399b6851facfea43e8d6c7ehttps://scholars.lib.ntu.edu.tw/handle/123456789/605301[SDGs]SDG3A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infectionjournal article10.1016/j.cgh.2014.10.035254605522-s2.0-84927912814